Related Experiment Video
Updated: Aug 14, 2026
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease
1Dept of Respiratory Medicine, University College Hospital, Galway, Ireland.
The European Respiratory Journal
|September 1, 1991
Summary
Immunoglobulin G (IgG) subclass levels are altered in chronic obstructive pulmonary disease (COPD). IgG2 subclass deficiency is common in COPD patients and correlates with reduced lung function (FEV1).
Area of Science:
- Immunology
- Pulmonology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue.
- Immunoglobulin G (IgG) subclass deficiencies have been implicated in various immune-related conditions.
Purpose of the Study:
- To investigate and compare immunoglobulin G (IgG) subclass levels in patients with COPD and healthy controls.
- To explore the relationship between IgG subclass levels, steroid therapy, smoking status, and pulmonary function in COPD.
Main Methods:
- Measurement of total IgG and IgG subclass levels (IgG1, IgG2, IgG3) in 58 COPD patients and 125 healthy controls.
- Comparison of IgG subclass levels between COPD patients (stratified by steroid use and smoking status) and controls.
- Correlation analysis between IgG subclass levels and forced expiratory volume in one second (FEV1) in COPD patients.
Main Results:
- Total IgG levels were lower in COPD patients on steroid therapy compared to those not on steroids.
- COPD patients not on steroids showed significantly reduced total IgG, IgG1, and IgG2 levels compared to controls.
- Elevated IgG3 levels were observed in smokers versus nonsmokers in both groups. IgG2 deficiency was the most prevalent (9 patients), correlating significantly with lower FEV1.
Conclusions:
- Immunoglobulin G (IgG) subclass deficiencies, particularly IgG2, are common in COPD patients.
- These deficiencies may play a role in the pathogenesis and progression of respiratory diseases in COPD.
- Reduced IgG2 levels are associated with impaired lung function in COPD patients.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...